Has Murali Chiravuri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $100,503 in general payments to Murali Chiravuri, MD across 106 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Murali Chiravuri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Murali Chiravuri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Murali Chiravuri, MD

Clinical Cardiac Electrophysiology · Fairfield, CTNPI 1952411704

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $72,275 of the $100,503 with a category attached, or 71.9%. Pfizer accounts for 61.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $74,375 and has fallen 89.5% since, to $7,821 in 2025. Among clinical cardiac electrophysiology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$100,503in general payments, 2019–2025

Across 106 payments — averaging $948.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$62K
E.r. Squibb & Sons, L.L.C.$36K
Abbott$1K
Medtronic$746
Bristol Myers Squibb$300
AstraZeneca$173
plus $150 from 4 others

What the payments were for

Consulting fees$12,41312%
Speaking & faculty fees$72,27572%
Travel & lodging$13,03013%
Food & beverage$2,7863%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	47	$61,554
E.r. Squibb & Sons, L.L.C.	28	$36,358
Abbott	12	$1,222
Medtronic	8	$746
Bristol Myers Squibb	1	$300
AstraZeneca	2	$173
Boston Scientific	3	$74
Johnson & Johnson	2	$37
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$24
Novartis	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$100,503 in reported general payments places this provider in the 90th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.

See all clinical cardiac electrophysiology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$217,785

Medicare patients

991

Services billed

2,671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	150	$192,670
CamzyosMavacamten	18	$144,726
XareltoRivaroxaban	23	$28,373
Dofetilide	51	$14,576
Metoprolol Succinate	137	$2,003
Flecainide Acetate	22	$1,104
Rosuvastatin Calcium	80	$1,100
Diltiazem 24hr Er (Cd)Diltiazem Hcl	48	$959
Amiodarone Hcl	42	$858
Propafenone Hcl	19	$662
Verapamil ErVerapamil Hcl	16	$546
Losartan Potassium	36	$498
Carvedilol	35	$469
Atorvastatin Calcium	48	$381
Lisinopril	39	$293

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$61,554	$192,670150 claims
E.r. Squibb & Sons, L.L.C.Camzyos	$36,358	$144,72618 claims
Johnson & JohnsonXarelto	$37	$28,37323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.

Other clinical cardiac electrophysiology in Fairfield

Robert WinslowFairfield$47K
Bryan LawlorFairfield$5K
Joseph Dell OrfanoHartford$160K
Paras BhattNorwich$139K
Steven ZweibelHartford$125K
James FreemanNew Haven$87K
Jude ClancyMiddletown$84K
Joseph TianoTrumbull$70K
Michael PittaroStamford$70K
Neal LippmanHartford$69K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →